Fig 1 - by Junhui Kim (18575083)

Fig 1 - by Kellie J. Walters (10451329)

EZH2 and HDAC inhibitors cooperatively derepress a subset of PRC2 targets in CRPC. by Amy E. Schade (15368259)

Data of research. by Natália de Souza Duarte (18264611)

“…The root mean square of a 5-second contraction period, peak root mean square values, area values, % maximal voluntary contraction (root mean square normalized by peak signal), and median frequency were collected. …”

Sample characterization (n = 30). by Natália de Souza Duarte (18264611)

“…The root mean square of a 5-second contraction period, peak root mean square values, area values, % maximal voluntary contraction (root mean square normalized by peak signal), and median frequency were collected. …”

Flowchart of sample eligibility. by Natália de Souza Duarte (18264611)

“…The root mean square of a 5-second contraction period, peak root mean square values, area values, % maximal voluntary contraction (root mean square normalized by peak signal), and median frequency were collected. …”

Fig 8 - by Junhui Kim (18575083)

Fig 3 - by Kellie J. Walters (10451329)

Fig 8 - by Kellie J. Walters (10451329)

Fig 5 - by Kellie J. Walters (10451329)

Overall analysis of randomized controlled trials. by Solima Sabeel (9545738)

“…Notably, atorvastatin demonstrated the most significant reduction in IL-6 and TNF-α levels, while fluvastatin and rosuvastatin displayed the greatest impact on decreasing CRP and LDL-C levels, respectively. Stratification by a longer treatment duration of more than four months revealed that atorvastatin achieved the most significant reduction in IL-6 and TNF-α. …”

Newcastle-Ottawa scale. by Solima Sabeel (9545738)

“…Notably, atorvastatin demonstrated the most significant reduction in IL-6 and TNF-α levels, while fluvastatin and rosuvastatin displayed the greatest impact on decreasing CRP and LDL-C levels, respectively. Stratification by a longer treatment duration of more than four months revealed that atorvastatin achieved the most significant reduction in IL-6 and TNF-α. …”

Fig 2 - by Kellie J. Walters (10451329)

Fig 4 - by Maris Lohmöller (16985922)

Fig 7 - by Kellie J. Walters (10451329)

Time adjusted survival curves for high vs. low renalase among patients with COVID-19 disease (using first quartile as cutoff). by Basmah Safdar (12213257)

DUOX activation upon HPx1 silencing and hierarchical mode of activation of innate immunity in the mosquito midgut. by Octavio A. C. Talyuli (4285141)

Patients’ demographics and clinical parameters. by Zi-Rong Chen (9227618)

“…Regression analysis was used to develop a model of AL changes with time. A generalized estimating equation (GEE) model was then used to identify correlations between the early AL changes and long-term AL changes.…”

Uchida-Kraepelin Test and Psychomotor Vigilance Task following simulated night shift. by Sanae Oriyama (11597047)

PCA map and heatmap. by Takumi T. Shito (11849291)